Treatment of Post-Cesarean Section Infections

First-Line Treatment Options

The Infectious Diseases Society of America recommends clindamycin 900 mg IV every 8 hours plus gentamicin 5-7 mg/kg IV every 24 hours as a first-line treatment regimen for post-cesarean section infections, providing excellent coverage against aerobic and anaerobic pathogens 1
Ampicillin-sulbactam 3 g IV every 6 hours is an alternative regimen, providing good coverage against common pathogens in post-cesarean infections, particularly for patients without severe infection 2, 3
Piperacillin-tazobactam 3.375-4.5 g IV every 6-8 hours is a broad-spectrum option, useful for more severe infections 1, 2, 4

For penicillin-allergic patients, the American College of Obstetricians and Gynecologists recommends cefazolin 2 g IV every 8 hours for non-severe reactions, and clindamycin 900 mg IV every 8 hours plus gentamicin 5-7 mg/kg IV every 24 hours for severe reactions 1
For suspected MRSA infections, vancomycin 15-20 mg/kg IV every 8-12 hours should be added to the regimen, and cultures should be obtained to guide targeted therapy 1, 4

The Centers for Disease Control and Prevention recommend continuing antibiotics until the patient is afebrile for 24-48 hours, with a typical course of 5-7 days, but may be extended for complicated infections 1
Transition to oral antibiotics may be appropriate when the patient is clinically improving and tolerating oral intake 2

The Society for Healthcare Epidemiology of America recommends monitoring temperature, white blood cell count, and clinical symptoms daily, and assessing renal function when using aminoglycosides 1, 2
Individualized aminoglycoside dosing based on lean body mass is recommended for optimal efficacy and reduced toxicity 1

For extended-spectrum cephalosporin-resistant Enterobacterales (ESCR-E), carbapenems (ertapenem 1 g IV daily) are preferred for severe infections, while aminoglycosides and piperacillin-tazobactam may be considered for less severe infections 2, 3

The American College of Surgeons recommends source control, including imaging to rule out retained products of conception or abscess formation, and drainage of any identified abscess when indicated 1